http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107001437-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-8114 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-8114 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57449 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6848 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N27-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate | 2015-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107001437-B |
| titleOfInvention | Detection methods and drugs for ovarian clear cell adenocarcinoma |
| abstract | An object of the present invention is to provide a method for detecting highly malignant ovarian clear cell adenocarcinoma with high sensitivity and specificity in benign or malignant ovarian tumors with various histological types, and a reagent that can be used for the method. The present invention provides a novel tissue factor pathway inhibitor 2 processing polypeptide, namely NT-TFPI2, as a new detection marker for ovarian clear cell adenocarcinoma. Ovarian clear cell adenocarcinoma is detected by measuring the amount of NT-TFPI2, or the total amount of NT-TFPI2 and intact TFPI2. In addition, the detection reagent for ovarian clear cell adenocarcinoma contains antibodies that specifically recognize NT-TFPI2 and intact TFPI2. |
| priorityDate | 2014-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 303.